MOTIV BTK Randomized Controlled Trial | MicrobiomeTrials← Back to trialsNCT05406622
MOTIV BTK Randomized Controlled Trial
RecruitingNAINTERVENTIONAL
Trial Details
Start: 2022-06-10Est. Completion: 2026-04-30
Enrollment target: 292 participants Locations- Adventist Health, St. Helena, California, United States
- Vascular Care Connecticut, Darien, Connecticut, United States
- Miami Cardiac & Vascular Institute, Miami, Florida, United States
- Palm Vascular, Miami Beach, Florida, United States
- UnityPoint Health Trinity Bettendorf Hospital, Bettendorf, Iowa, United States
- Cardiovascular Medicine PC, Davenport, Iowa, United States
- Cardiovascular Institute of the South, Houma, Louisiana, United States
- The Vascular Care Group - Wellesley, Wellesley, Massachusetts, United States
- Holy Name Medical Center, Teaneck, New Jersey, United States
- Ballad Health System, Kingsport, Tennessee, United States
- North Dallas Research Associates, McKinney, Texas, United States
- Bellin Memorial Hospital, Green Bay, Wisconsin, United States
- University Leipzig, Leipzig, Leipzig, Germany
Other microbiome trials you might be interested in
Critical Ischemia Limb
Peripheral arteriopathy disease (PAD) affects 1 million people in France. In its most advanced stage: chronic permanent …
Angers, FranceEst. completion Dec 2026
CLTI Defined as Rutherford Category 4 or 5PAOD (Peripheral Arterial Obstructive Disease)
The aim of this clinical trial is to learn if the resorbable scaffold can be successfully implanted in below-the-knee ar…
Tashkent, UzbekistanEst. completion Dec 1, 2026